Use of popular weight-loss medications, such as semaglutide and tirzepatide, was associated with a moderately lower risk for obesity-related cancers, especially colon and rectal cancer, and reduced overall mortality compared with another widely used class of diabetes drugs, according to a study presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place this week in Chicago
We should absolutely use them
Eating smaller meals and avoiding heavy foods often helps reduce these symptoms
GIP/GLP-1 co-agonists, developed by merging the respective peptide sequences, potently lower body weight in rodents and humans 27,28
Sudden fiber increases cause gas and bloating that compound the GLP-1 GI effects
This challenge can arise from everyday choices like our contraceptives, life phases such as menopause, or health issues like PCOS